Isoindolinone Synthesis via Cu(I) Catalysis and Inversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for the enantioselective synthesis of isoindolinones suffer from low yields and poor enantiomeric excesses, limiting their pharmacological effectiveness and industrial scalability.
Innovation Solution
A process for synthesizing isoindolinones with enantiomeric purity greater than 90% using 3-substituted isoindolinones as starting materials, involving decarboxylation and reduction reactions, and arylation with Cu(I) complexes, which maintains high enantiomeric purity throughout transformations.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If resolution of racemic mixture is used to obtain enantiomers, then enantiomeric purity is improved, but yield deteriorates to extremely low levels (4%)
Solution Approach 1:
Instead of resolving racemic mixtures to obtain enantiomers (traditional approach), the invention inverts the approach by using enantiomerically pure starting materials and maintaining stereochemical integrity throughout the synthesis pathway, thereby avoiding racemization and eliminating the need for resolution steps
Solution Approach 2:
The invention performs preliminary action by establishing enantiomeric purity at the earliest stage (starting materials) and preserving it through carefully controlled reaction conditions, rather than attempting to achieve enantiomeric purity at the final stage through resolution
2Manufacturing precision
If chiral catalysts with phase transfer are used for enantioselective preparation, then enantiomeric excess is improved, but versatility deteriorates as enantiomeric excess strongly depends on substrate and conditions
Solution Approach 1:
The invention changes parameters by using Cu(I) catalysis with specific ligands (L-proline, L-hydroxyproline) and controlled conditions (temperature, solvent, atmosphere) to achieve high enantiomeric excess across diverse substrates, demonstrating that parameter optimization can broaden substrate scope while maintaining stereocontrol
Solution Approach 2:
The Cu(I)-catalyzed aza-Michael reaction system demonstrates universality by effectively synthesizing various isoindolinone derivatives with different substituents (electron-withdrawing and electron-donating groups) under the same reaction conditions, achieving both broad substrate scope and high enantiomeric excess
3Manufacturing precision
If existing enantioselective methods are used, then some enantiomeric purity is achieved, but yield and enantiomeric excess simultaneously deteriorate
Solution Approach 1:
The invention uses Cu(I) complexes with chiral ligands as intermediaries to facilitate the aza-Michael reaction with high stereocontrol, where the catalyst mediates the reaction to achieve both high yield and high enantiomeric excess simultaneously
Solution Approach 2:
The invention optimizes reaction parameters including Cu(I) salt selection, ligand structure, temperature control, and atmosphere management to achieve a balance between reaction efficiency (yield) and stereochemical control (enantiomeric excess)
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process achieves high yields and enantiomeric excesses, enabling the production of pharmacologically active chiral compounds without racemization, enhancing scalability and reducing production costs.
Implementation Method 1
arylation with Cu(I) complexes
Implementation Method 2
decarboxylation and reduction reactions
Implementation Method 3
decarboxylation and reduction reactions
Data Source
AI summary
The present invention relates the asymmetrical synthesis of heterocyclic compounds of pharmaceutical interest. In particular a series of enantioselective methods is described, allowing the synthesis and transformations of isoindolinones of Formula (I), into high yields and enantiomeric excesses >90%.